Measure number |
Performance measure |
2016 Performance Summary Statistics |
ACO performance rate |
Mean Performance Rate (Next Generation Model ACOs) |
ACO-1 |
CAHPS: Getting Timley Care, Appointments, and Information |
84.81 |
81.91 |
ACO-2 |
CAHPS: How Well Your Providers Communicate |
93.79 |
93.15 |
ACO-3 |
CAHPS: Patients' Rating of Provider |
93.72 |
92.56 |
ACO-4 |
CAHPS: Access to Specialists |
82.29 |
83.33 |
ACO-5 |
CAHPS: Health Promotion and Education |
57.29 |
61.09 |
ACO-6 |
CAHPS: Shared Decision Making |
77.54 |
76.41 |
ACO-7 |
CAHPS: Health Status/Functional Status |
72.37 |
73.78 |
ACO-34 |
CAHPS: Stewardship of Patient Resources* |
33.27 |
26.14 |
ACO-8 |
Risk Standardized, All Condition Readmissions |
15.17 |
14.75 |
ACO-35 |
Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission |
18.15 |
18.56 |
ACO-36 |
All-Cause Unplanned Admissions for Patients with Diabetes* |
67.43 |
53.05 |
ACO-37 |
All-Cause Unplanned Admissions for Patients with Heart Failure* |
89.04 |
75.78 |
ACO-38 |
All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions |
71.17 |
60.74 |
ACO-9 |
Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5 |
11.41 |
8.79 |
ACO-10 |
Ambulatory Sensitive Conditions Admission: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 |
20.28 |
14.79 |
ACO-39 |
Documentation of Current Medications in the Medical Record* |
32.96% |
77.74% |
ACO-13 |
Falls: Screening for Future Fall Risk |
81.34% |
67.45% |
ACO-14 |
Preventive Care and Screening: Influenza Immunization |
75.21% |
72.70% |
ACO-15 |
Pneumonia Vaccination Status for Older Adults |
67.70% |
75.18% |
ACO-16 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up Plan |
69.96% |
70.21% |
ACO-17 |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
80.76% |
92.96% |
ACO-18 |
Preventive Care and Screening: Screening for Clinical Depression and Follow-up |
63.46% |
56.92% |
ACO-19 |
Colorectal Cancer Screening |
58.59% |
65.75% |
ACO-20 |
Breast Cancer Screening |
71.09% |
72.92% |
ACO-21 |
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
72.55% |
70.22% |
ACO-42 |
Statin therapy for the Prevention and Treatment of Cardiovascular Disease |
73.91% |
81.31% |
ACO-40 |
Depression Remission at Twelve Months |
10.71% |
5.99% |
ACO-27 |
Diabetes Mellitus: Hemoglobin A1c Poor Control |
14.19% |
19.49% |
ACO-41 |
Diabetes: Eye Exam |
39.79% |
49.58% |
ACO-28 |
Hypertension (HTN): Controlling High Blood Pressure |
67.63% |
73.95% |
ACO-30 |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
84.19% |
86.42% |
ACO-31 |
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
83.52% |
88.24% |
ACO-33 |
Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy- for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) |
79.1% |
79.71% |
CAHPS= Consumer Assessment of Healthcare Providers and Systems, PQI= Prevention Quality Indicator, LVSD= left ventricular systolic dysfunction, ACE= angiotensin-converting enzyme, ARB= angiotensin receptor blocker, CAD= coronary artery disease |
|